NIFTY 50

Biocon: The Pegfilgrastim opportunity

Updated : May 28, 2018 10:30 AM IST

Biosimilars are better propostions for companies.
The USFDA has approved Biocon's first biosimilar applications in the US in 2017,
Biocon: The Pegfilgrastim opportunity
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV